Anti-Infective Agents Completed Phase 1 Trials for Cephalexin (DB00567)

IndicationStatusPhase
DBCOND0046346 (Anti-Infective Agents)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01073540Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin SuspensionTreatment
NCT01105208Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin SuspensionTreatment
NCT01073553Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin CapsulesTreatment